Pay in 4 interest-free payments of $5.19 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Once consequence of obesity fatty liver disease showed normalization of liver fat in 9/10 people on one of the new GLP-1 medicines
I was prediabetic, my joints hurt and I had zero energy
They have the potential to radically reduce food waste due to a reduction in food consumption, they could potentially halve obesity, and they could lead to an increase in fortification
Because these medications reduce appetite and slow digestion, its important to prioritize nutrient-dense foods that deliver maximum nourishment in smaller portions
Common side effects include: Nausea Vomiting Diarrhea Headache Fatigue Delayed gastric emptying More serious risks include: Kidney issues: Patients are advised to stay hydrated to avoid dehydration
Tirzepatide is currently approved by Health Canada for use in type 2 diabetes ( Mounjaro ) and weight management ( Zepbound) but is currently not approved for use with T1D
